Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
CA 2421920 A1 · Owner: Pharmacia Italia S.P.A. · Inventors: Colombo, Paolo; Buzzi, Giovanni; Muggetti, Lorena
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use of arginine and more in particular, to the injectable formulations for intravenous use comprising it in the , prevention and treatment of the side effects associated with the extravasation of drugs administered by intravenous route.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 7, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 7, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 7, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.